These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8078950)

  • 1. Report on the fifth consensus conference: methodology of long-term clinical trials in psychiatry.
    Angst J; Bech P; Bruinvels J; Engel RR; Ferner U; Guelfi JD; Lingjaerde O; Müller-Oerlinghausen B; Paes de Sousa M; Paykel E
    Pharmacopsychiatry; 1994 May; 27(3):101-7. PubMed ID: 8078950
    [No Abstract]   [Full Text] [Related]  

  • 2. Report on the Fourth Consensus Conference on the Methodology of Clinical Trials with Anxiolytic Drugs.
    Angst J; Ansseau M; Bech P; Engel RR; Hippius H; Lader M; Lecrubier Y; Lingjaerde O; de Sousa MP; Rossi A
    Pharmacopsychiatry; 1993 Jan; 26(1):1-5. PubMed ID: 8104347
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term outcome of anxiety disorders: a review of double-blind studies.
    Thuile J; Even C; Rouillon F
    Curr Opin Psychiatry; 2009 Jan; 22(1):84-9. PubMed ID: 19122539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chlormezanone on anxiety and tension: a double blind study.
    Friedman D; Moskowitz MD; Rosen M; Rossman M; Sheppard C; Merlis S
    Curr Ther Res Clin Exp; 1966 Jan; 8(1):7-11. PubMed ID: 4955147
    [No Abstract]   [Full Text] [Related]  

  • 5. [CUtLASS 1 - Increasing disillusion about 2nd generation neuroleptics].
    Steinert T
    Psychiatr Prax; 2007 Jul; 34(5):255-7. PubMed ID: 17607643
    [No Abstract]   [Full Text] [Related]  

  • 6. Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.
    Pollack MH; Endicott J; Liebowitz M; Russell J; Detke M; Spann M; Ball S; Swindle R
    J Psychiatr Res; 2008 Oct; 42(12):1042-9. PubMed ID: 18221755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: Chan et al. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int J Geriatr Psychiatry 16: 1156 - 1162.
    Onalaja D; Jainer AK
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1076-7; author reply 1077. PubMed ID: 12404659
    [No Abstract]   [Full Text] [Related]  

  • 8. Relapse prevention in schizophrenia: evidence from longterm, randomized, double-blind clinical trials.
    Pecenak J
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():49-70. PubMed ID: 17262007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Informed consent. Trials that use Zelen's procedure should be acceptable.
    House A; Knapp P
    BMJ; 1997 Jul; 315(7102):251. PubMed ID: 9253287
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders.
    Lenzi A; Lazzerini F; Placidi GF; Cassano GB; Akiskal HS
    Pharmacopsychiatry; 1989 Jan; 22(1):34-7. PubMed ID: 2652160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methodology of clinical trials in migraine: a rating system].
    Tzourio C; Massiou H; Bousser MG
    Pathol Biol (Paris); 1992 Apr; 40(4):361-6. PubMed ID: 1495821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication group for psychiatric patients.
    Cohen M; Amdur MA
    Am J Nurs; 1981 Feb; 81(2):343-5. PubMed ID: 6906955
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medical treatment of psychiatric disorders in alcoholics].
    Wetterling T
    Psychiatr Prax; 2001 Sep; 28(6):257-61. PubMed ID: 11533889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia.
    Kasper S
    Depress Anxiety; 2004; 20(1):44-7. PubMed ID: 15368596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuing education. Clinical trials].
    Sökeland J
    Urologe A; 1990 Nov; 29(6):W41-2. PubMed ID: 2291253
    [No Abstract]   [Full Text] [Related]  

  • 17. Antipsychotic medications in children and adolescents.
    Findling RL; Grcevich SJ; Lopez I; Schulz SC
    J Clin Psychiatry; 1996; 57 Suppl 9():19-23. PubMed ID: 8823346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of carbamazepine in psychiatric disorders.
    Birkhimer LJ; Curtis JL; Jann MW
    Clin Pharm; 1985; 4(4):425-34. PubMed ID: 2864160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Problems in testing new drugs in the hospital and general practice (phase III)].
    Blumenbach L
    Med Welt; 1981 Feb; 32(7):210-2. PubMed ID: 7207155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.